JUDITH L. SWAIN, M.D. - Corporate Board Profile

LEXICON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2008-03-14	Judith L. Swain, M.D. has been a director since September 2007. ... The current members of the corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2007 regarding the compensation of the non-employee members of our board of directors. ... Judith L. Swain, M.D. $7,519 Fees Earned or Paid in Cash, $3,755 Option Awards, Total $11,274.
2009-03-13	The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc.
2010-03-19	The following table presents summary information for the year ended December 31, 2009 regarding the compensation of the non-employee members of our board of directors. Samuel L. Barker, Ph.D. $48,500 $14,946 — $63,446 Philippe J. Amouyal $30,500 $7,473 — $37,973 Raymond Debbane $32,000 $7,473 — $39,473 Robert J. Lefkowitz, M.D. $28,500 $7,473 $50,000 (4) $85,973 Alan S. Nies, M.D. $30,000 $7,473 $75,000 (5) $112,473 Frank P. Palantoni $37,000 $7,473 — $44,473 Christopher J. Sobecki $27,000 $7,473 — $34,473 Judith L. Swain, M.D. $29,500 $7,473 — $36,973 Kathleen M. Wiltsey $28,000 $7,473 — $35,473
2011-03-18	Judith L. Swain, M.D. has been a director since September 2007. Dr. Swain is the executive director of the Singapore Institute for Clinical Sciences within A*STAR, and the Lien Chow Professor of Medicine at the National University of Singapore. From 2005 to 2006, she was the dean for translational medicine at the University of California, San Diego. Dr. Swain served as chair of the Department of Medicine at Stanford University from 1997 to 2005, and previously served on the medical faculties of the University of Pennsylvania and Duke University. Dr. Swain is currently a director of the Burroughs Wellcome Fund and a member of the Council of the Institute of Medicine, National Academies of Science. She has served in a number of national and international leadership roles and as a director or member of the scientific advisory boards for a number of biomedical technology companies and is co-founder of Synecor, LLC. Dr. Swain received her B.S. from the University of California, Los Angeles and her M.D. from the University of California, San Diego. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Dr. Barker, Mr. Palantoni and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. Each non-employee member of our board of directors currently receives the following cash compensation: an annual retainer of $15,000 for service on the board of directors ($30,000 for service as non-executive chairman of the board of directors), prorated for any partial year of service; an annual retainer of $2,500 for service on each committee of the board of directors of which he or she is a member ($5,000 for service as chairman of any such committee), prorated for any partial year of service; a fee of $2,500 for each meeting of the board of directors that he or she attends in person ($500 for each telephonic meeting of the board of directors in which he or she participates); and a fee of $1,000 for each committee meeting that he or she attends in person other than in connection with a meeting of the full board of directors ($500 for each telephonic committee meeting in which he or she participates). The following table presents summary information for the year ended December 31, 2010 regarding the compensation of the non-employee members of our board of directors. Judith L. Swain, M.D. Fees Earned or Paid in Cash: $29,108, Option Awards: $11,979, Total: $41,087.
2012-03-16	Judith L. Swain, M.D. has been a director since September 2007. Dr. Swain provides us with the benefit of her extensive medical and scientific research experience.
2013-03-25	Judith L. Swain, M.D. has been a director since September 2007. ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2012 regarding the compensation of the non-employee members of our board of directors. ... Judith L. Swain, M.D. $32,000 Fees Earned or Paid in Cash, $25,922 Option Awards, $19,999 Restricted Stock Awards, Total $77,921.
2014-03-14	The following table presents summary information for the year ended December 31, 2013 regarding the compensation of the non-employee members of our board of directors. Name: Judith L. Swain, M.D. Fees Earned or Paid in Cash: $31,500 Option Awards: $30,074 Restricted Stock Awards: $30,074 All Other Compensation: $20,000 Total: $81,574
2015-03-13	Judith L. Swain, M.D. has been a director since September 2007. Audit Committee member. Corporate Governance Committee member. Director compensation table shows $76,965 total compensation in 2014.
2016-03-18	Judith L. Swain, M.D. has been a director since September 2007 ... The current members of our audit committee are ... Judith L. Swain, M.D. ... The current members of our corporate governance committee are ... Judith L. Swain, M.D. ... Director Compensation in 2015 ... Judith L. Swain, M.D. $68,363
2017-03-17	The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Dr. Barker, Mr. Palantoni and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... Director Compensation in 2016 ... Judith L. Swain, M.D. ... $81,707 ...
2018-03-16	Judith L. Swain, M.D. has been a director since September 2007. Dr. Swain provides us with the benefit of her extensive medical and scientific research experience. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Dr. Swain is “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. The following table presents summary information for the year ended December 31, 2017 regarding the compensation of the non-employee members of our board of directors. Judith L. Swain, M.D. received total compensation of $81,924 in 2017.
2019-03-15	Judith L. Swain, M.D. has been a director since September 2007. ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2018 regarding the compensation of the non-employee members of our board of directors. ... Judith L. Swain, M.D. $31,000 Fees Earned or Paid in Cash, $14,888 Option Awards, $19,999 Restricted Stock Awards, Total $65,887.
2020-03-13	Judith L. Swain, M.D. has been a director since September 2007 ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2019 regarding the compensation of the non-employee members of our board of directors. ... Judith L. Swain, M.D. $52,753 Fees Earned or Paid in Cash, $24,460 Option Awards, $19,652 Restricted Stock Unit Awards, Total $96,865.
2021-03-19	Judith L. Swain, M.D. has been a director since September 2007. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D.
2022-04-08	Judith L. Swain, M.D. has been a director since September 2007. Dr. Swain is a visiting professor of medicine at the National University of Singapore and chief medical officer of Physiowave, Inc. She previously served as founding director of the Singapore Institute for Clinical Sciences, dean for translational medicine at the University of California, San Diego, chair of the Department of Medicine at Stanford University, and on the medical faculties of the University of Pennsylvania and Duke University. She has previously served in a number of national and international leadership roles and as a director or member of the scientific advisory boards for a number of biomedical technology companies and is co-founder of Synecor, LLC. Dr. Swain has served as a director of Prometheus Biosciences, Inc. since February 2021. Dr. Swain received her B.S. from the University of California, Los Angeles and her M.D. from the University of California, San Diego. Dr. Swain provides us with the benefit of her extensive medical and scientific research experience gained in her more than 30 years as a practicing physician and research scientist, as well as her organizational and management skills developed in her numerous leadership positions with a variety of prominent research and academic institutions. Director Compensation in 2021: $105,621.
2023-03-17	The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Dr. Barker, Mr. Palantoni and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... The following table presents summary information for the year ended December 31, 2022 regarding the compensation of the non-employee members of our board of directors. ... Judith L. Swain, M.D. $60,000 Fees Earned or Paid in Cash, $20,387 Option Awards, $16,465 Restricted Stock Unit Awards, Total $96,852.
2024-03-26	Judith L. Swain, M.D. has been a director since September 2007. Dr. Swain provides us with the benefit of her extensive medical and scientific research experience. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Diane E. Sullivan and Judith L. Swain, M.D. The current members of our compensation committee are Philippe J. Amouyal (chair), Samuel L. Barker, Ph.D. and Judith L. Swain, M.D. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The following table presents summary information for the year ended December 31, 2023 regarding the compensation of the non-employee members of our board of directors. Judith L. Swain, M.D. received $62,133 in fees and $42,824 in stock awards in 2023, totaling $104,957.